Ticker archive · $DBVT

$DBVT Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $DBVT — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

?? Positive AI Sentiment (+3.0 / 10)
  • Submitted Biologics License Application (BLA) to US FDA for Viaskin Peanut Patch (ages 4-7) with Priority Review requested.
  • Q3 2026 net loss widened to $64.5M vs $33.2M prior year due to ramped commercial readiness costs.
  • Q3 EPS stood at -$0.14 compared to -$0.24 in Q3 2025.